- Home
- HROW vs SUPX Comparison
HROW vs SUPX Comparison
Compare HROW & SUPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HROW
- SUPX
- Stock Information
- Founded
- HROW 1998
- SUPX 2021
- Country
- HROW United States
- SUPX Singapore
- Employees
- HROW N/A
- SUPX N/A
- Industry
- HROW Biotechnology: Pharmaceutical Preparations
- SUPX
- Sector
- HROW Health Care
- SUPX
- Exchange
- HROW Nasdaq
- SUPX Nasdaq
- Market Cap
- HROW 1.4B
- SUPX 1.4B
- IPO Year
- HROW N/A
- SUPX 2024
- Fundamental
- Price
- HROW $39.74
- SUPX $69.71
- Analyst Decision
- HROW Strong Buy
- SUPX
- Analyst Count
- HROW 7
- SUPX 0
- Target Price
- HROW $68.50
- SUPX N/A
- AVG Volume (30 Days)
- HROW 889.7K
- SUPX 295.6K
- Earning Date
- HROW 11-12-2025
- SUPX 11-07-2025
- Dividend Yield
- HROW N/A
- SUPX N/A
- EPS Growth
- HROW N/A
- SUPX N/A
- EPS
- HROW N/A
- SUPX N/A
- Revenue
- HROW $227,661,000.00
- SUPX $1,978,875.00
- Revenue This Year
- HROW $43.92
- SUPX N/A
- Revenue Next Year
- HROW $41.32
- SUPX N/A
- P/E Ratio
- HROW N/A
- SUPX N/A
- Revenue Growth
- HROW 47.69
- SUPX N/A
- 52 Week Low
- HROW $20.85
- SUPX $2.75
- 52 Week High
- HROW $59.23
- SUPX $76.50
- Technical
- Relative Strength Index (RSI)
- HROW 45.21
- SUPX 63.20
- Support Level
- HROW $40.79
- SUPX $63.10
- Resistance Level
- HROW $48.79
- SUPX $57.71
- Average True Range (ATR)
- HROW 2.41
- SUPX 7.39
- MACD
- HROW -0.87
- SUPX 0.58
- Stochastic Oscillator
- HROW 11.18
- SUPX 80.79
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
About SUPX Super X AI Technology Limited Ordinary Shares
Super X AI Technology Ltd is an AI infrastructure solutions provider. Through its subsidiaries, SuperX offers a comprehensive portfolio of proprietary hardware, advanced software, and end-to-end services for AI data centers. The Company's services include advanced solution design and planning, cost-effective infrastructure product integration, and end-to-end operations and maintenance. Its core products include high-performance AI servers, High-Voltage Direct Current (HVDC) solutions, high-density liquid cooling solutions, as well as AI cloud and AI agents. The Company serves institutional clients globally, including enterprises, research institutions, and cloud and edge computing deployments.